Condensed Balance Sheets - USD ($)	Jun. 30, 2021	Dec. 31, 2020
Current Assets:
Cash	$ 449,773	$ 25,000
Prepaid expenses	383,813
Total current assets	833,586	25,000
Deferred offering costs associated with proposed initial public offering		131,695
Other assets	384,996
Cash equivalents held in Trust Account	250,008,083
Total Assets	251,226,665	156,695
Current Liabilities:
Accrued expenses	46,630	94,560
Payables to related party	424,773	37,640
Sponsor loan - promissory notes	1,040,144
Franchise tax payable	90,909
Total Current Liabilities	1,602,456	132,200
Warrant liability	9,386,666
Forward purchase securities liability	2,218,092
Total Liabilities	13,207,214	132,200
Commitments and Contingencies (Note 5)
Class A common stock, subject to possible redemption, 23,301,945 shares at redemption value of $10.00 per share as of June 30, 2021	233,019,450
Stockholders’ Equity:
Preferred stock, $0.0001 par value; 1,000,000 shares authorized; none issued and outstanding as of both June 30, 2021 and December 31, 2020
Common stock, Class A, $0.0001 par value; 240,000,000 shares authorized; 2,298,055 issued and outstanding (excluding 23,301,945 shares subject to possible redemption) as of June 30, 2021 and no shares issued and outstanding as of December 31, 2020	230
Common stock, Class B, $0.0001 par value; 30,000,000 shares authorized; 6,250,000 and 7,187,500 shares issued and outstanding at June 30, 2021 and December 31, 2020, respectively	625	719
Additional paid-in capital	7,113,662	24,281
Accumulated deficit	(2,114,516)	(505)
Total Stockholders’ Equity	5,000,001	24,495
Total Liabilities and Stockholders’ Equity	$ 251,226,665	$ 156,695